We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Review · September 13, 2021

Pre-Admission GLP-1RA and Mortality From COVID-19

Diabetes Research and Clinical Practice


Additional Info

Diabetes Research and Clinical Practice
Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): A systematic review, meta-analysis, and meta-regression
Diabetes Res. Clin. Pract. 2021 Aug 28;[EPub Ahead of Print], TI Hariyanto, D Intan, JE Hananto, C Putri, A Kurniawan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading